DYAI
- Dyadic International, Inc.
()
Overview
Company Summary
Dyadic International, Inc. (DYAI) is a biotechnology company primarily engaged in the development, manufacturing, and licensing of enzymes and other proteins used in various applications. The company specializes in using its proprietary C1 gene expression platform technology to produce high-performance enzymes at industrial scale.
DYAI focuses on the discovery and optimization of enzymes for use in industries such as biofuels, animal health and nutrition, food and beverage, and industrial applications. By harnessing the power of its C1 technology, the company is able to produce enzymes with improved performance and cost-effectiveness compared to traditional methods.
Dyadic's C1 technology enables the rapid development and efficient production of enzymes by utilizing a fungal expression system. This system offers advantages such as high productivity, scalability, and the ability to produce proteins with specific properties. The company also offers access to its technology through research and development collaborations, licensing agreements, and joint ventures.
In addition to its core enzyme production and licensing activities, Dyadic also focuses on developing its own product pipeline and continuously improving its C1 technology platform. The company's goal is to provide innovative solutions to industry participants, enabling them to improve efficiency, sustainability, and profitability in their respective sectors.
Overall, Dyadic International, Inc. plays a vital role in the biotechnology industry by providing advanced enzyme technologies, manufacturing capabilities, and research collaborations to address industrial challenges and improve the performance of various applications.